Viktor Umansky
Impact in
- Immunology top 0.5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 75
- Immune cells in cancer 51
- Immunotherapy and Immune Responses 23
- Immune Cell Function and Interaction 13
- Immune Response and Inflammation 12
- Oncology 45
- Cancer Immunotherapy and Biomarkers 21
- Chemokine receptors and signaling 11
- CAR-T cell therapy research 7
- Co-authors
- Jochen Utikal (50 shared papers)Alexandra Sevko (10 shared papers)Christoffer Gebhardt (14 shared papers)Peter Altevogt (18 shared papers)C Blattner (6 shared papers)Rebekka Weber (12 shared papers)Christopher Groth (12 shared papers)Samantha Lasser (10 shared papers)
- Journals
- OncoImmunology (10 papers)Cancer Immunology Immunotherapy (9 papers)Cancer Research (6 papers)International Journal of Cancer (6 papers)Cancers (6 papers)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Viktor Umansky
94 papers receiving 5.8k citations
Viktor Umansky's Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 3.5k
- Oncology 2.6k
- Cancer Research 560
- Molecular Biology 1.6k
- Neurology 157
Countries citing papers authored by Viktor Umansky
This map shows the geographic impact of Viktor Umansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Umansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Umansky more than expected).
Fields of papers citing papers by Viktor Umansky
This network shows the impact of papers produced by Viktor Umansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Umansky. The network helps show where Viktor Umansky may publish in the future.
Co-authors
The 25 scholars most cited alongside Viktor Umansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors Hit paper breakdown → | 2018 | 419 |
| 2 | 2016 | 337 | |
| 3 | Myeloid-derived suppressor cells in cancer and cancer therapy Hit paper breakdown → | 2024 | 260 |
| 4 | 2014 | 248 | |
| 5 | 2020 | 228 | |
| 6 | 2013 | 214 | |
| 7 | 2013 | 208 | |
| 8 | 2018 | 156 | |
| 9 | 2014 | 146 | |
| 10 | 2012 | 139 | |
| 11 | 2012 | 138 | |
| 12 | 2018 | 137 | |
| 13 | 2012 | 137 | |
| 14 | 2015 | 122 | |
| 15 | 2011 | 116 | |
| 16 | 2019 | 114 | |
| 17 | 2012 | 110 | |
| 18 | 2012 | 100 | |
| 19 | 2020 | 96 | |
| 20 | 2018 | 95 |
About Viktor Umansky
Viktor Umansky is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Biomedical Engineering, having authored 95 papers that have together received 5.9k indexed citations. Recurring topics across this work include Immune cells in cancer (51 papers), Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (21 papers), Immune Cell Function and Interaction (13 papers), Immune Response and Inflammation (12 papers), Chemokine receptors and signaling (11 papers), Extracellular vesicles in disease (8 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Immunology (3.5k citations), Oncology (2.6k citations), Cancer Research (560 citations), Molecular Biology (1.6k citations) and Neurology (157 citations). Viktor Umansky has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Jochen Utikal, Alexandra Sevko, Christoffer Gebhardt, Peter Altevogt, C Blattner, Rebekka Weber, Christopher Groth, Samantha Lasser, Ihor Arkhypov and Xiaoying Hu. Their work appears in journals such as OncoImmunology, Cancer Immunology Immunotherapy, Cancer Research, International Journal of Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.